(Reuters) - Pfizer Inc will pay $55 million plus interest to settle charges that Wyeth promoted its acid reflux drug Protonix for unapproved uses and made unproven claims about the medicine, the U.S.
THE DEAL: Two generic drugmakers will pay $2.15 billion to Pfizer Inc. and Takeda Pharmaceuticals to resolve a lawsuit over the heartburn drug Protonix. THE LAUNCH: Teva Pharmaceutical Industries Ltd.
LOS ANGELES, July 31 (Reuters) - Wyeth and its partner Nycomed said on Tuesday that Teva Pharmaceuticals and Sun Pharmaceuticals have committed to not launching generic versions of heartburn drug ...
NEW YORK (AP) — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results